α-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C (original) (raw)
References
Kurstak E: Hepatitis C and hepatitis E viruses: Epidemiology and transmission.In Viral Hepatitis. Current Status and Issues. E Kurstak (ed). Wien, Springer-Verlag, 1993, pp 181–184 Google Scholar
Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M: A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47–53, 1993 Google Scholar
Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326–1333, 1993 Google Scholar
Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801, 1993 Google Scholar
Imberti D, Fornari F, Sbolli G, Buscarini E, Squassante L, Buscarini L: Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand J Gastroenterol 28:540–544, 1993 Google Scholar
Bruix J, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, Barrera JM, Ercilla G, Sanchez-Tapias JM, Vall M, Bru C, Rodes J: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 28:1004–1006, 1989 Google Scholar
Colombo M, Rumi MG, Donato MF, Tommasini MA, Del Ninno E, Ronchi G, Kuo G, Houghton M: Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci 36: 1130–1133, 1991 Google Scholar
Lee SD, Lee FY, Wu JC, Hwang SJ, Wang SS, Lo KJ: The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 69:342–345, 1992 Google Scholar
Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H, Tokunaga K, Irita Y, Takeshita S, Arase Y, Nishino N: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 51:2842–2847, 1991 Google Scholar
Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325:675–680, 1991 Google Scholar
Munoz N, Bosch FX: Epidemiology of hepatocellular carcinoma.In Neoplasms of the Liver. K Okuda, KG Ishak (eds). Tokyo, Springer-Verlag, 1987, pp 3–19 Google Scholar
Cottone M, Turri M, Caltagirone M, Maringhini A, Sciarrino E, Virdone R, Fusco G, Orlando A, Marino L, Pagliaro L: Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and α-fetoprotein: A prospective study. Hepatogastroenterology 35:101–103, 1988 Google Scholar
Okuda K: Early recognition of hepatocellular carcinoma. Hepatology 6:729–738, 1986 Google Scholar
Ikeda K, Saitoh S, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H: Imaging diagnosis of small hepatocellular carcinoma. Hepatology 20:82–87, 1994 Google Scholar
Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S: Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19:61–66, 1994 Google Scholar
Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328:1802–1806, 1993 Google Scholar
Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327, 1993 Google Scholar
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49–53, 1991 Google Scholar
Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453–456, 1991 Google Scholar
Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53:2884–2887, 1993 Google Scholar
Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S: p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54:231–235, 1994 Google Scholar
Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR: p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9:195–204, 1994 Google Scholar
Collier JD, Carpenter M, Burt AD, Bassendine MF: Expression of mutant p53 protein in hepatocellular carcinoma. Gut 35:98–100, 1994 Google Scholar
Laurent-Puig P, Flejou JF, Fabre M, Bedossa P, Belghiti J, Gayral F, Franco D: Overexpression of p53: A rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 16:1171–1175, 1992 Google Scholar
Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B: p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108:1176–1182, 1995 Google Scholar
Crawford LV, Pim DC, Bulbrook RD: Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30:403–408, 1982 Google Scholar
Legros Y, Meyer A, Ory K, Soussi T: Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein. Oncogene 9:3689–3694, 1994 Google Scholar
Volkmann M, Müller M, Hofmann WJ, Meyer M, Hagelstein J, Räth U, Kommerell B, Zentgraf H, Galle PR: The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α-fetoprotein status. Hepatology 18:559–565, 1993 Google Scholar
Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP: Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52:4168–4174, 1992 Google Scholar
Bukh J, Purcell RH, Miller RH: Importance of primer selection for the detection of hepatitis C virus RNA with polymerase chain reaction assay. Proc Natl Acad Sci USA 89:187–189, 1992 Google Scholar
Zeuzem S, Rüster B, Roth WK: Clinical evaluation of a new polymerase chain reaction assay (AmplicorTM HCV) for detection of hepatitis C virus. Z Gastroenterol 32:342–347, 1994 Google Scholar
Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 64:1700–1707, 1989 Google Scholar
Kondo F, Wada K, Nagato Y, Nakajima T, Kondo Y, Hirooka N, Ebara M, Ohto M, Okuda K: Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9:751–755, 1989 Google Scholar
Peng SY, Lai PL, Chu JS, Lee PH, Tsung PT, Chen DS, Hsu HC: Expression and hypomethylation of α-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma. Hepatology 17:35–41, 1993 Google Scholar
Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, McMahon BJ, Lanier AP, London WT, Redeker AG, Govindarajan S: Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc Natl Acad Sci USA 89:9622–9626, 1992 Google Scholar
Davidoff AM, Iglehart JD, Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancer. Proc Natl Acad Sci USA 89:3439–3442, 1992 Google Scholar
Labrecque S, Naor N, Thomson D, Matlashewski G: Analysis of the anti-p53 antibody response in cancer patients. Cancer Res 53:3468–3471, 1993 Google Scholar
Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P: Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317–1319, 1994 Google Scholar
Unsal H, Yakicier C, Marçais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, Ozturk M: Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 91:822–826, 1994 Google Scholar